VTVT - vTv Therapeutics EPS beats by $0.05 beats on revenue November, 09 2021 09:00 AM vTv Therapeutics Inc. vTv Therapeutics (NASDAQ:VTVT): Q3 GAAP EPS of -$0.02 beats by $0.05. Revenue of $3M (+29900.0% Y/Y) beats by $2.35M. Shares -1.33% PM. Press Release For further details see: vTv Therapeutics EPS beats by $0.05, beats on revenue